Possible Predictive Markers of Response to Therapy in Esophageal Squamous Cell Cancer

Laszló Zoltan, Robert Farkas, Andrew V Schally, Eva Pozsgai, Andras Papp, Laura Bognár, Tamas Tornoczki, Laszlo Mangel, Szabolcs Bellyei

Research output: Contribution to journalArticle

Abstract

The aim of the present study was to investigate the relationship between the intensity of biomarker expression and the response to radiochemotherapy in patients with advanced esophageal squamous cell cancer (ESCC). Ninety-two patients with locally advanced ESCC were examined retrospectively. Pre-treatment tumor samples were stained for proteins SOUL, Hsp 16.2, Growth Hormone-Releasing Hormone Receptor (GHRH-R) and p-Akt using immunhistochemistry methods. Kaplan-Meier curves were used to show the relationship between intensity of expression of biomarkers and clinical parameters and 3-year OS. A significant correlation was found between high intensity staining for Hsp 16.2, p-Akt and SOUL and poor response to NRCT. Application of a higher dose of radiation and higher dose of cisplatin resulted in better clinical and histopathological responses, respectively. Among the clinical parameters, the localization of the tumor in the upper-third of the esophagus and less than 10% weight loss were independent prognostic factors for increased 3-year OS. Hsp16.2, p-Akt and SOUL are predictors of negative response to NRCT, therefore these biomarkers may become promising targets for therapy. Furthermore, level of expression of p-Akt, weight loss and the localization of the tumor are significant factors in the prediction of OS in ESCC.

Original languageEnglish (US)
Pages (from-to)1-10
Number of pages10
JournalPathology and Oncology Research
DOIs
StateAccepted/In press - Nov 4 2017

Fingerprint

Squamous Cell Neoplasms
Esophageal Neoplasms
Biomarkers
Weight Loss
Neoplasms
Chemoradiotherapy
Cisplatin
Esophagus
Therapeutics
Radiation
Staining and Labeling
Proteins

Keywords

  • AKT
  • Esopageal cancer
  • Predictiv factors
  • Radiochemotherapy
  • Small heat shock protein

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Oncology
  • Cancer Research

Cite this

Possible Predictive Markers of Response to Therapy in Esophageal Squamous Cell Cancer. / Zoltan, Laszló; Farkas, Robert; Schally, Andrew V; Pozsgai, Eva; Papp, Andras; Bognár, Laura; Tornoczki, Tamas; Mangel, Laszlo; Bellyei, Szabolcs.

In: Pathology and Oncology Research, 04.11.2017, p. 1-10.

Research output: Contribution to journalArticle

Zoltan, L, Farkas, R, Schally, AV, Pozsgai, E, Papp, A, Bognár, L, Tornoczki, T, Mangel, L & Bellyei, S 2017, 'Possible Predictive Markers of Response to Therapy in Esophageal Squamous Cell Cancer', Pathology and Oncology Research, pp. 1-10. https://doi.org/10.1007/s12253-017-0342-z
Zoltan, Laszló ; Farkas, Robert ; Schally, Andrew V ; Pozsgai, Eva ; Papp, Andras ; Bognár, Laura ; Tornoczki, Tamas ; Mangel, Laszlo ; Bellyei, Szabolcs. / Possible Predictive Markers of Response to Therapy in Esophageal Squamous Cell Cancer. In: Pathology and Oncology Research. 2017 ; pp. 1-10.
@article{4f5033ea51b448e4804cb20e833ecc03,
title = "Possible Predictive Markers of Response to Therapy in Esophageal Squamous Cell Cancer",
abstract = "The aim of the present study was to investigate the relationship between the intensity of biomarker expression and the response to radiochemotherapy in patients with advanced esophageal squamous cell cancer (ESCC). Ninety-two patients with locally advanced ESCC were examined retrospectively. Pre-treatment tumor samples were stained for proteins SOUL, Hsp 16.2, Growth Hormone-Releasing Hormone Receptor (GHRH-R) and p-Akt using immunhistochemistry methods. Kaplan-Meier curves were used to show the relationship between intensity of expression of biomarkers and clinical parameters and 3-year OS. A significant correlation was found between high intensity staining for Hsp 16.2, p-Akt and SOUL and poor response to NRCT. Application of a higher dose of radiation and higher dose of cisplatin resulted in better clinical and histopathological responses, respectively. Among the clinical parameters, the localization of the tumor in the upper-third of the esophagus and less than 10{\%} weight loss were independent prognostic factors for increased 3-year OS. Hsp16.2, p-Akt and SOUL are predictors of negative response to NRCT, therefore these biomarkers may become promising targets for therapy. Furthermore, level of expression of p-Akt, weight loss and the localization of the tumor are significant factors in the prediction of OS in ESCC.",
keywords = "AKT, Esopageal cancer, Predictiv factors, Radiochemotherapy, Small heat shock protein",
author = "Laszl{\'o} Zoltan and Robert Farkas and Schally, {Andrew V} and Eva Pozsgai and Andras Papp and Laura Bogn{\'a}r and Tamas Tornoczki and Laszlo Mangel and Szabolcs Bellyei",
year = "2017",
month = "11",
day = "4",
doi = "10.1007/s12253-017-0342-z",
language = "English (US)",
pages = "1--10",
journal = "Pathology and Oncology Research",
issn = "1219-4956",
publisher = "Springer Netherlands",

}

TY - JOUR

T1 - Possible Predictive Markers of Response to Therapy in Esophageal Squamous Cell Cancer

AU - Zoltan, Laszló

AU - Farkas, Robert

AU - Schally, Andrew V

AU - Pozsgai, Eva

AU - Papp, Andras

AU - Bognár, Laura

AU - Tornoczki, Tamas

AU - Mangel, Laszlo

AU - Bellyei, Szabolcs

PY - 2017/11/4

Y1 - 2017/11/4

N2 - The aim of the present study was to investigate the relationship between the intensity of biomarker expression and the response to radiochemotherapy in patients with advanced esophageal squamous cell cancer (ESCC). Ninety-two patients with locally advanced ESCC were examined retrospectively. Pre-treatment tumor samples were stained for proteins SOUL, Hsp 16.2, Growth Hormone-Releasing Hormone Receptor (GHRH-R) and p-Akt using immunhistochemistry methods. Kaplan-Meier curves were used to show the relationship between intensity of expression of biomarkers and clinical parameters and 3-year OS. A significant correlation was found between high intensity staining for Hsp 16.2, p-Akt and SOUL and poor response to NRCT. Application of a higher dose of radiation and higher dose of cisplatin resulted in better clinical and histopathological responses, respectively. Among the clinical parameters, the localization of the tumor in the upper-third of the esophagus and less than 10% weight loss were independent prognostic factors for increased 3-year OS. Hsp16.2, p-Akt and SOUL are predictors of negative response to NRCT, therefore these biomarkers may become promising targets for therapy. Furthermore, level of expression of p-Akt, weight loss and the localization of the tumor are significant factors in the prediction of OS in ESCC.

AB - The aim of the present study was to investigate the relationship between the intensity of biomarker expression and the response to radiochemotherapy in patients with advanced esophageal squamous cell cancer (ESCC). Ninety-two patients with locally advanced ESCC were examined retrospectively. Pre-treatment tumor samples were stained for proteins SOUL, Hsp 16.2, Growth Hormone-Releasing Hormone Receptor (GHRH-R) and p-Akt using immunhistochemistry methods. Kaplan-Meier curves were used to show the relationship between intensity of expression of biomarkers and clinical parameters and 3-year OS. A significant correlation was found between high intensity staining for Hsp 16.2, p-Akt and SOUL and poor response to NRCT. Application of a higher dose of radiation and higher dose of cisplatin resulted in better clinical and histopathological responses, respectively. Among the clinical parameters, the localization of the tumor in the upper-third of the esophagus and less than 10% weight loss were independent prognostic factors for increased 3-year OS. Hsp16.2, p-Akt and SOUL are predictors of negative response to NRCT, therefore these biomarkers may become promising targets for therapy. Furthermore, level of expression of p-Akt, weight loss and the localization of the tumor are significant factors in the prediction of OS in ESCC.

KW - AKT

KW - Esopageal cancer

KW - Predictiv factors

KW - Radiochemotherapy

KW - Small heat shock protein

UR - http://www.scopus.com/inward/record.url?scp=85032816909&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032816909&partnerID=8YFLogxK

U2 - 10.1007/s12253-017-0342-z

DO - 10.1007/s12253-017-0342-z

M3 - Article

C2 - 29103201

AN - SCOPUS:85032816909

SP - 1

EP - 10

JO - Pathology and Oncology Research

JF - Pathology and Oncology Research

SN - 1219-4956

ER -